First Universities Allied for Essential Medicines (UAEM) neglected diseases and innovation symposium

Laura W. Musselwhite, Karolina Maciag, Alex Lankowski, Michael C. Gretes, Thomas E. Wellems, Gloria Tavera, Rebecca E. Goulding, Ethan Guillen

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Universities Allied for Essential Medicines organized its first Neglected Diseases and Innovation Symposium to address expanding roles of public sector research institutions in innovation in research and development of biomedical technologies for treatment of diseases, particularly neglected tropical diseases. Universities and other public research institutions are increasingly integrated into the pharmaceutical innovation system. Academic entities now routinely undertake robust high-throughput screening and medicinal chemistry research programs to identify lead compounds for small molecule drugs and novel drug targets. Furthermore, product development partnerships are emerging between academic institutions, non-profit entities, and biotechnology and pharmaceutical companies to create diagnostics, therapies, and vaccines for diseases of the poor. With not for profit mission statements, open access publishing standards, open source platforms for data sharing and collaboration, and a shift in focus to more translational research, universities and other public research institutions are well-placed to accelerate development of medical technologies, particularly for neglected tropical diseases.

Original languageEnglish (US)
Pages (from-to)65-74
Number of pages10
JournalAmerican Journal of Tropical Medicine and Hygiene
Issue number1
StatePublished - Jan 2012

ASJC Scopus subject areas

  • Parasitology
  • Virology
  • Infectious Diseases


Dive into the research topics of 'First Universities Allied for Essential Medicines (UAEM) neglected diseases and innovation symposium'. Together they form a unique fingerprint.

Cite this